Total submissions: 2
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Center for Genomic Medicine, |
RCV002466020 | SCV002760392 | uncertain significance | not specified | 2025-03-04 | criteria provided, single submitter | clinical testing | |
Ambry Genetics | RCV004681485 | SCV005170095 | uncertain significance | Inborn genetic diseases | 2024-05-30 | criteria provided, single submitter | clinical testing | The c.289T>C (p.F97L) alteration is located in exon 3 (coding exon 3) of the TFR2 gene. This alteration results from a T to C substitution at nucleotide position 289, causing the phenylalanine (F) at amino acid position 97 to be replaced by a leucine (L). Based on insufficient or conflicting evidence, the clinical significance of this alteration remains unclear. |